Cargando…
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis
BACKGROUND: Obesity is increasingly prevalent in pulmonary arterial hypertension (PAH) but is associated with improved survival, creating an “obesity paradox” in PAH. It is unknown if the improved outcomes could be attributable to obese patients deriving a greater benefit from PAH therapies. RESEARC...
Autores principales: | McCarthy, Breanne E., McClelland, Robyn L., Appleby, Dina H., Moutchia, Jude S., Minhas, Jasleen K., Min, Jeff, Mazurek, Jeremy A., Smith, K. Akaya, Fritz, Jason S., Pugliese, Steven C., Urbanowicz, Ryan J., Holmes, John H., Palevsky, Harold I., Kawut, Steven M., Al-Naamani, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470735/ https://www.ncbi.nlm.nih.gov/pubmed/35247393 http://dx.doi.org/10.1016/j.chest.2022.02.041 |
Ejemplares similares
-
Systemic arterial properties in pulmonary hypertension
por: Goodman, Randi, et al.
Publicado: (2021) -
Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension
por: Han, Yuchi, et al.
Publicado: (2018) -
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase
por: DiNicolantonio, James J, et al.
Publicado: (2020) -
Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland
por: Stubbs, Harrison, et al.
Publicado: (2022) -
Evaluation of Recirculation During Venovenous Extracorporeal Membrane Oxygenation Using Computational Fluid Dynamics Incorporating Fluid-Structure Interaction
por: Conrad, Steven A., et al.
Publicado: (2020)